BioRegen Overview

  • Year Founded
  • 2008

Year Founded

  • Status
  • Public

  • Employees
  • 200

Employees

  • Stock Symbol
  • 920201

Stock Symbol

  • Share Price
  • $3.15
  • (As of Friday Closing)

BioRegen General Information

Description

BioRegen Biomedical Changzhou Co Ltd is engaged in the research, development, production and sales of biomedical materials and other products.

Contact Information

Ownership Status
Publicly Held
Financing Status
Formerly VC-backed
Corporate Office
  • Block B, Kangsite Industrial Park
  • No. 117 Xueye Road, Xinbei District
  • Changzhou, Jiangsu 213125
  • China
+86 0519
Primary Industry
Pharmaceuticals
Other Industries
Drug Discovery
Biotechnology
Stock Exchange
BJSE
Vertical(s)
Corporate Office
  • Block B, Kangsite Industrial Park
  • No. 117 Xueye Road, Xinbei District
  • Changzhou, Jiangsu 213125
  • China
+86 0519

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

BioRegen Stock Performance

As of 20-Nov-2026, BioRegen’s stock price is $3.15. Its current market cap is $215M with 68.2M shares.

(As of Friday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$3.15 $3.37 $3.14 - $14.45 $215M 68.2M 2.44M $0.20

BioRegen Financials Summary

As of 30-Sep-2026, BioRegen has a trailing 12-month revenue of $47.8M.

In Thousands,
USD
TTM 30-Sep-2026 FY 2025 31-Dec-2025 FY 2024 31-Dec-2024 FY 2023 31-Dec-2023
EV 428,262
Revenue 47,771 39,474 32,225 28,012
EBITDA 13,132 8,937 8,885
Net Income 11,926 10,616 7,290 7,078
Total Assets 84,563 54,287 41,112 34,424
Total Debt 2,562 1,167 1,130 1,426
Public Fundamental Data provided by Morningstar, Inc. disclaimer

BioRegen Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore BioRegen‘s full profile, request access.

Request a free trial

BioRegen Patents

BioRegen Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2025112235-A1 Encapsulated hyaluronic acid gel composition, method for preparing same, and use thereof Inactive 28-Nov-2023
WO-2024222313-A1 Method for preparing sulfhydrylated natural polysaccharide derivative Inactive 24-Apr-2023
WO-2021077681-A1 Hyaluronic acid gel composition for water optoinjection, and preparation method therefor Inactive 23-Oct-2019
WO-2021077683-A1 Hyaluronic acid gel for hyaluronic acid injection and use method for hyaluronic acid gel Inactive 23-Oct-2019
AU-2020348245-A1 Disulfide bond-linked hyaluronic acid gel for preventing tissue adhesion after abdominal or pelvic cavity surgery and preparation method therefor Active 21-Sep-2019 A61L31/042
To view BioRegen’s complete patent history, request access »

BioRegen Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

BioRegen FAQs

  • When was BioRegen founded?

    BioRegen was founded in 2008.

  • Where is BioRegen headquartered?

    BioRegen is headquartered in Changzhou, China.

  • What is the size of BioRegen?

    BioRegen has 200 total employees.

  • What industry is BioRegen in?

    BioRegen’s primary industry is Pharmaceuticals.

  • Is BioRegen a private or public company?

    BioRegen is a Public company.

  • What is BioRegen’s stock symbol?

    The ticker symbol for BioRegen is 920201.

  • What is the current stock price of BioRegen?

    As of 20-Nov-2026 the stock price of BioRegen is $3.15.

  • What is the current market cap of BioRegen?

    The current market capitalization of BioRegen is $215M.

  • What is BioRegen’s current revenue?

    The trailing twelve month revenue for BioRegen is $47.8M.

  • What is BioRegen’s annual earnings per share (EPS)?

    BioRegen’s EPS for 12 months was $0.20.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process